Rating History for SAB Biotherapeutics (SABS) by Barclays

More Stocks Rated by Barclays | Latest Ratings for SABS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/24/2026 Eliana Merle New Coverage Overweight
(N/A)		 13.00
(N/A)		 3.87
(3.54)		 -8.53% Details